Ninety-Nine Percent of Life Sciences and High-Tech Leaders Expect AI to Drive Revenue Management Value in 2025Model N’s 2025 State of Revenue Report reveals shifts toward use of generative AI and automation to bolster pharmaceutical, medtech, and high-tech revenue programs
Model N Appoints New Chief Executive Officer, Bret ConnorConnor’s expertise in healthcare and technology will guide Model N’s next phase of growth
Model N Achieves ISO/IEC 27001 Certification, the Global Standard for Information SecurityLatest certification demonstrates the company’s commitment to exceeding industry requirements for data security and compliance
Vista Equity Partners Completes Acquisition of Model N
Model N, a leader in revenue optimization and compliance for pharmaceutical, medtech, and high-tech innovators, today announced the completion of its acquisition by Vista Equity Partners (“Vista”), a leading global investment firm focused exclusively on enterprise software, data, and technology-enabled businesses, for $30.00 per share in cash in a transaction that values the Company at approximately $1.25 billion. With the completion of the transaction, Model N’s common stock ceased trading, and the Company is no longer listed on the New York Stock Exchange.
Model N Introduces Two Cutting-Edge Data Solutions, Syndicated Customer Master and Formulary ComplianceRevenue Optimization leader introduces new integrated data solutions that accelerate time to insight, improve decision making, and strengthen compliance for life sciences manufacturers.
Model N Announces Date of Second Quarter Fiscal Year 2024 Financial ResultsSAN MATEO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Model N, Inc. (
NYSEMODN), a leader in revenue optimization and compliance, plans to announce financial results for the second quarter fiscal year 2024 pre-market on Monday, May 6, 2024. Due to the Company’s pending acquisition by Vista Equity Partners that was announced on April 8, 2024, there will not be a conference call or live webcast to discuss the financial results.
Model N to be Acquired by Vista Equity Partners For $1.25 Billion
Model N (
NYSEMODN), a leader in revenue optimization and compliance for pharmaceutical, medtech, and high-tech innovators, today announced that it has entered into a definitive agreement to be acquired by Vista Equity Partners (“Vista”), a leading global investment firm focused exclusively on enterprise software, data, and technology-enabled businesses.
Model N Management to Participate in Upcoming Investor ConferencesSAN MATEO, Calif, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Model N, Inc. (
NYSEMODN), the leader in cloud revenue management solutions, today announced that Model N management will present at the following investor conferences:
Nearly Two-Thirds of Life Sciences and High-Tech Executives Set Sights on Advanced Analytics and AI to Improve Revenue Optimization and Profitability in 2024Model N’s 2024 State of Revenue Report uncovers how pharmaceutical, medical technology, and high-tech manufacturing executives solve for revenue optimization and compliance.
Model N Launches Price Management to Help High-Tech Companies Streamline PricingNew solution accelerates business agility and profitability by automating pricing processes
Model N Launches Channel Collaboration to Strengthen Visibility for High-Tech Manufacturers and Their Channel Partners
Model N (
NYSEMODN), the leader in revenue optimization and compliance today announced the launch of Channel Collaboration, a new self-service portal for high-tech manufacturers and their channel partners. Channel Collaboration provides high-tech manufacturers and their partners real-time visibility into channel data, enabling faster and more informed business decisions while maintaining channel compliance.
Model N Responds to Mounting Regulatory Pharma Pressures with Innovations that Ensure Compliance and Optimize Revenue
Model N (
NYSEMODN), the leader in revenue optimization and compliance today announced new product innovations geared towards the increasingly complex regulatory environment for global pharma manufacturers. Model N’s latest product enhancements relating to 340B, the Inflation Reduction Act (IRA), and global pricing help pharma manufacturers effectively manage duplicate discounts and maintain compliance with evolving U.S. and international regulations.
Model N Board of Directors Named a Finalist in NACD DE&I AwardsSAN MATEO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Model N, Inc. (
NYSEMODN), the leader in revenue optimization and compliance, today announced that its Board of Directors has been named a finalist in the National Association of Corporate Directors (NACD) 2023 Diversity, Equity & Inclusion (DE&I) Awards.
Model N Earns Recognition for Company Culture, Named by Fortune as a Best Place to Work for Millennial Employees
Fortune Media and Great Place To Work® have honored Model N (
NYSEMODN) as one of this year’s Best Workplaces for Millennials. This prestigious accolade highlights the company's commitment to fostering a supportive, engaging, and flexible work environment for its employees. This year’s Fortune Best Workplaces for Millennials 2023 list was based on nearly 500,000 millennial survey responses from eligible companies.
Model N Spring 2023 Release Introduces 340B Vigilance Solution for Pharma; Enhances Global Tendering for Life Sciences and Increases Business Agility for High-Tech Customers
Model N (
NYSEMODN), the leader in revenue optimization and compliance, today announced its Spring 2023 product release for life sciences and high-tech customers. This latest semi-annual release delivers new products and platform enhancements to help pharmaceutical, medical technology, and high-tech manufacturers further optimize revenue operations and strengthen compliance across the enterprise.
